Chronic Lung Diseases Active Not Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Lung Disease / Lung Diseases / Chronic Lung Disease / Calcification of lung / Disorder lung / Lung disorder / Lung disorder (NOS) / Lung disorder NOS / Pulmonary disorder / Disorder pulmonary / Pneumopathy

IndicationStatusPhase
DBCOND0044039 (Chronic Lung Diseases)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02909452Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid TumorsTreatment